Peled Y, Gilboa Y, Perri T, Shohat M, Chen R, Bar J, Hod M, Pardo J
Perinatal Division and WHO Collaborating Center for Perinatal Care, Center for Women's Health, and Department of Medical Genetics, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel.
Prenat Diagn. 2003 Nov;23(11):888-90. doi: 10.1002/pd.719.
Studies in the early 1990s showed that the normal levels of the biochemical markers used to screen for Down syndrome in the second trimester of pregnancy differ between healthy women and women with insulin-dependent diabetes mellitus (IDDM). Thereafter, most laboratories adopted correcting factors to adjust for these differences. However, the current validity of these factors in light of the recent improvements in glycemic control in diabetic pregnancy has not been investigated.
The sample consisted of 35 pregnant women with strictly controlled IDDM and 40 healthy controls matched for age and gestational week. All women had singleton pregnancies and were followed till delivery.
Comparison of the triple test results between the two groups after adjustment with the traditional corrective factors yielded no significant differences in serum levels of any of the markers (unconjugated estriol, human chorionic gonadotrophin, alpha-fetoprotein).
These results suggest that the recent improvement in glycemic control of pregnant women with IDDM changes the metabolic milieu that might cause the biochemical differences with healthy pregnant patients.
20世纪90年代初的研究表明,用于孕期中期唐氏综合征筛查的生化标志物正常水平在健康女性和胰岛素依赖型糖尿病(IDDM)女性之间存在差异。此后,大多数实验室采用校正因子来调整这些差异。然而,鉴于近期糖尿病妊娠血糖控制的改善,这些因子目前的有效性尚未得到研究。
样本包括35名IDDM得到严格控制的孕妇和40名年龄及孕周匹配的健康对照。所有女性均为单胎妊娠,并随访至分娩。
用传统校正因子调整后,两组间三联试验结果比较显示,任何标志物(未结合雌三醇、人绒毛膜促性腺激素、甲胎蛋白)的血清水平均无显著差异。
这些结果表明,近期IDDM孕妇血糖控制的改善改变了可能导致与健康孕妇生化差异的代谢环境。